Subscribe free
The independent voice of UK resident doctors220 conferences · 6 journals 55 societies · 290+ resources

MedicMess

The first UK medical conference website

Conferences · Journals · Societies · Research, for UK resident doctors

Home›Conferences›Dementia Research and Clinical Care›Alzheimer's Association International Conference 2026
Dementia Research and Clinical Care · Annual Conference

Alzheimer's Association International Conference 2026

Organised by the Alzheimer's Association
Dates12–15 Jul 2026
VenueExcel London
CityLondon, United Kingdom
FormatIn-person + Hybrid
CPD Points25 CPD
The largest international dementia-science meeting, bringing researchers, clinicians, early-career investigators and the care-research community to London and online for four days of scientific sessions, plenaries, posters and networking.
Reviewed byDr Robert BaxterDr Robert Baxter· Junior Clinical Fellow, Acute Medical Unit· Updated 14 Jul 2026
MedicMess Conference Intelligence
Networking
Daily poster and exhibit periods, ISTAART activities, a welcome reception, member reception and AAIC After Hours provide structured networking.
Research Value
More than 800 podium presentations and 4,000 posters are advertised, with peer review and selection by the Scientific Program Committee.
Trainee Relevance
Postdoctoral researchers, medical residents and fellows qualify for the postdoctoral registration category; students have dedicated reduced rates.
Cpd
Up to 25 AMA PRA Category 1 Credits are available; credit purchase and claiming are separate from registration.
Audience
Dementia researchers, clinicians, early-career investigators, care researchers and allied professionals worldwide.
Programme Highlights
Key Themes
Basic science and pathogenesisBiomarkers and neuroimagingClinical manifestationsDementia care and psychosocial factorsDrug developmentPublic health and prevention
08:00–08:45
Scientific session
Scientific Sessions
09:00–10:30
Scientific session
Scientific Sessions
11:00–12:15
Plenary
Accelerating the Discovery and Development of Medicines for Neurodegenerationkeynote
Ryan Watts, Ph.D.
12:15–14:00
Posters and networking
Boxed lunch with exhibits, posters and product theater presentations
14:00–15:30
Scientific session
Scientific Sessions
15:40–16:10
Interactive
ASK! Sessions
16:15–17:45
Scientific session
Scientific Sessions
17:45–19:00
Reception
Welcome Reception
Keynote Speakers
Keynote
RW
Ryan Watts, Ph.D.
Denali Therapeutics
Accelerating the Discovery and Development of Medicines for Neurodegeneration
Keynote
SE
Suzanne E. Schindler, M.D., Ph.D.
Washington University in St. Louis
Eligibility for Anti-Amyloid Immunotherapy: Amyloid Biomarkers in the Real World
Keynote
DA
Daisy Acosta, M.D.
Universidad Nacional Pedro Henriquez Ureña and Asociación Dominicana de Alzheimer
Understanding Dementia in Latin America: New Insights from the 10/66 Studies
Keynote
TC
Takaomi C. Saido, Ph.D.
RIKEN Center for Brain Science and Keio University School of Medicine
From Curiosity to Cure: The Neprilysin-Donanemab and Amyloid Beta-Tau Axes in Alzheimer’s Disease
Keynote
BT
Betty Tijms, Ph.D.
Amsterdam UMC and Amsterdam Neuroscience
Proteomic Subtypes of AD: What Do They Mean and How Will They Influence or Benefit Drug Development for Alzheimer's Disease?
Keynote
ZI
Zahinoor Ismail, M.D.
University of Calgary and University of Exeter
Neuropsychiatric Manifestations of Alzheimer's Disease and Other Dementia
Keynote
DA
Dag Aarsland, M.D.
King's College London and Stavanger University Hospital
Prevalence of Alzheimer’s Disease Pathology in the Community
Abstract Submission Guide
Abstract submissions are closed
Deadline: 12 January 2026
What You Can Submit
oralpostercase studysession proposal
Submission Specifications
Notes
Full detailed specifications are in the official 2026 submission-guide PDF.
Structure
Structured abstracts are required for Featured Research Session presenters; Perspectives and Clinical Toolbox session abstracts are unstructured.
Eligibility
Original, update and encore research abstracts; case studies are accepted. Presenting authors may attend in person or virtually.
Presenter Requirement
All poster presenters must register.
Categories & Recommended Topics
Basic Science and Pathogenesis
Biomarkers
Clinical Manifestations
Dementia Care and Psychosocial Factors
Drug Development
Public Health

MedicMess Tips

  • General abstract submissions closed 12 January 2026; the ISTAART extension closed 16 January.
  • Developing Topics submissions closed 11 April 2026 and were normally poster-only unless late-breaking.
  • Registration rates are in USD and exclude VAT.
  • Continuing education is an optional add-on; credit claiming opens 16 July and closes 1 October 2026.
  • The Welcome Reception is included; the ISTAART Member Reception and AAIC After Hours require pre-registration.
Key Deadlines
12 Jan 2026
Abstract submission deadline
12 Jul 2026
Conference begins
Practical Information
By TrainExcel London is served by the Elizabeth line and DLR; use the venue's official visitor guidance for the best station for your hall.
AccommodationOfficial conference housing is available through bnetwork after registration.
Venue DetailsExcel London, Royal Victoria Dock, 1 Western Gateway, London E16 1XL
Nearest AirportLondon City Airport is approximately 2 miles away; Heathrow Airport is approximately 35 miles away.
Conference Snapshot
SpecialtyDementia Research and Clinical Care
Organising societyAlzheimer's Association
CPD accreditation25 CPD points
Conference formatIn-person + Hybrid
LocationExcel London, London
The Complete Guide to the Alzheimer's Association International Conference 2026

AAIC 2026 runs at Excel London from 12–15 July with online access and a large mixed scientific and clinical programme. The published schedule combines early scientific sessions, daily plenaries, poster and exhibit periods, ISTAART intermissions and skills workshops, ASK! sessions, corporate symposia and evening receptions. Seven named plenary speakers cover neurodegeneration drug discovery, anti-amyloid eligibility and biomarkers, dementia in Latin America, amyloid-beta and tau biology, proteomic subtypes, neuropsychiatric manifestations and community prevalence of Alzheimer’s pathology.

The general abstract deadline was 12 January 2026, with an ISTAART extension to 16 January and a Developing Topics window from 31 March to 11 April. Original, update and encore abstracts could be considered for oral or poster presentation, in person or virtually; case studies were also accepted. Six required themes structure submissions: basic science and pathogenesis, biomarkers, clinical manifestations, dementia care and psychosocial factors, drug development, and public health. A full submission guide is PDF-only; presenters must register. Original and update abstracts are published through Alzheimer’s & Dementia, while encore abstracts are excluded from republication.

Registration is priced in US dollars plus VAT. In-person non-member rates are USD 1,185 professional, USD 655 postdoctoral and USD 420 student; virtual non-member rates are USD 360, USD 235 and USD 120 respectively. ISTAART members receive substantial discounts, including free virtual attendance in several categories. Continuing education is optional and costs USD 75 for members or USD 150 for non-members. The activity offers up to 25 AMA PRA Category 1 Credits for physicians. London City Airport is the closest airport to Excel London; Heathrow is around 35 miles away.